Regencell Bioscience Holdings (Regencell Bioscience Holdings) Pre-Tax Income : $-6.06 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Regencell Bioscience Holdings's pretax income for the six months ended in Jun. 2023 was $-2.75 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was $-6.06 Mil. Regencell Bioscience Holdings's pretax margin was %.

Regencell Bioscience Holdings Pre-Tax Income Historical Data

The historical data trend for Regencell Bioscience Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Pre-Tax Income Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Pre-Tax Income

-0.39

-0.81

-1.35

-7.60

-6.06

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Pre-Tax Income	Get a 7-Day Free Trial				-1.01	-3.66	-3.94	-3.32	-2.75

Competitive Comparison of Regencell Bioscience Holdings's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's Pre-Tax Income falls into.

Regencell Bioscience Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Regencell Bioscience Holdings's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-6.274	+	0.211	+	0	+	0	+	0.00099999999999945
	=	-6.06

Regencell Bioscience Holdings's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.844	+	0.097	+	0	+	0	+	0
	=	-2.75

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-6.06 Mil.

Regencell Bioscience Holdings (NAS:RGC) Pre-Tax Income Explanation

Regencell Bioscience Holdings's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-2.747	/	0
	=	%

Regencell Bioscience Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.